Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ACIU stock hub

AC Immune SA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ACIUis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

283.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ACIU

In the news

Latest news · ACIU

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-104.8

P25 -106.6P50 -46.9P75 -3.1

ROIC-59.2

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ACIU market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

185

Groups with data

Currency

CHF

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001651625
Company name	AC Immune SA
Country	Switzerland
Country code	US
Cusip	H00263105
Employees	122
Employees Change	-50%
Employees Change Percent	-29.07
Enterprise value	$195.8M
Exchange	NASDAQ
Financial currency	CHF
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2016-09-23
Isin	CH0329023102
Last refreshed	2026-05-10
Market cap	$283.7M
Market cap category	Micro-Cap
Price	$2.86
Price currency	USD
Rev Per Employee	37,830.08x
Sector	Healthcare
Sic	2834
Symbol	ACIU
Website	https://www.acimmune.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-29.1%
EV Sales Forward	4.9x
EV/Sales	42.43x
P/B ratio	7.18x
P/S ratio	61.47x
PS Forward	7.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-65.7M
Net Income	$-82.6M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-1,788.74%
Profit Per Employee	$-676,680
ROA	-23.06
Roa5y	-19.18
ROCE	-142.3
ROE	-104.8
Roe5y	-45.56
ROIC	-59.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	72.35%
Cagr3y	11.11%
Cagr5y	-14.2%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	-86.92x
Revenue Growth Q	13.03x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-2.01x
Revenue Growth5 Y	3.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.02
Assets	$171.3M
Cash	$93.2M
Current Assets	$103M
Current Liabilities	$118.7M
Debt	$5.4M
Debt Equity	$0.14
Equity	$39.3M
Interest Coverage	-318.2
Liabilities	$132M
Long Term Assets	$68.3M
Long Term Liabilities	$13.3M
Net Cash	$87.9M
Net Cash By Market Cap	$30.98
Net Cash Growth	-49.81%
Net Debt Equity	$-2.24
Tangible Book Value	$-23.5M
Tangible Book Value Per Share	$-0.24
WACC	13.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.87
Net Working Capital	$-107.4M
Quick ratio	0.83
Working Capital	$-15.2M
Working Capital Turnover	$0.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.43%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	72.29%
200-day SMA	2.92
3Y total return	37.17%
50-day SMA	2.97
50-day SMA vs 200-day SMA	50over200
5Y total return	-53.5%
All Time High	19.97
All Time High Change	-85.68%
All Time High Date	2016-09-28
All Time Low	1.43
All Time Low Change	100%
All Time Low Date	2025-04-09
ATR	0.19
Beta	1.65
Beta1y	1.28
Beta2y	1.31
Ch YTD	-8.92
High	3
High52	4
High52 Date	2025-10-29
High52ch	-28.5%
Low	2.8
Low52	1.51
Low52 Date	2025-05-14
Low52ch	89.4%
Ma50ch	-3.54%
Premarket Change Percent	-0.37
Premarket Price	$2.91
Premarket Volume	274
Price vs 200-day SMA	-1.99%
RSI	44.72
RSI Monthly	49.21
RSI Weekly	48.39
Sharpe ratio	1.02x
Sortino ratio	1.81
Total Return	-0.43%
Tr YTD	-8.92
Tr1m	-8.04%
Tr1w	-4.03%
Tr3m	-8.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.2
Earnings Revenue Estimate	1,000,000x
Earnings Revenue Estimate Growth	-9.17x
Operating Income	$-80.1M
Operating margin	-1,736.4
Price target	$8
Price Target Change	$180

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	38,852,226%
Float Percent	39.17%
Shares Insiders	5.83%
Shares Institutions	6.19%
Shares Out	99,201,152
Shares Qo Q	-2.37%
Shares Yo Y	0.43%
Short Ratio	11.85
Short Shares	6.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	246,171.5x
Bv Per Share	0.4
Ch1m	-8.04
Ch1w	-4.03
Ch1y	72.29
Ch3m	-8.92
Ch3y	37.17
Ch5y	-53.5
Ch6m	-13.33
Change	-2.05%
Change From Open	-2.72
Close	2.92
Days Gap	0.68
Depreciation Amortization	1,776,486.4
Dollar Volume	980,382.3
Earnings Date	2026-04-30
Earnings Time	bmo
EBIT	$-80.1M
EBITDA	$-78.4M
EPS	$-0.82
F Score	0
Fiscal Year End	December
Founded	2,003
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-13
Ma150	3.11
Ma150ch	-8.01%
Ma20	3
Ma20ch	-4.73%
Next Earnings Date	2026-08-04
Open	2.94
Optionable	Yes
Position In Range	30
Post Close	2.86
Postmarket Change Percent	2.8
Postmarket Price	$2.94
Ppne	8,194,811.8
Pre Close	2.92
Price Date	2026-05-08
Relative Volume	1.39x
Revenue	4,615,270x
Tr6m	-13.33%
Volume	342,791

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ACIU pay a dividend?

Capital-return profile for this ticker.

Performance

ACIU stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ACIU?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.2%

Float: +39.2% of shares outstanding

Insider ownership

+5.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ACIU momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.7

Neutral momentum band

Price vs 200-day MA

-2.0%

50/200-day relationship not available

Beta (5Y)

1.65

More volatile than the market

Sharpe ratio

1.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ACIU

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ACIU stock rating?

AC Immune SA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ACIU analysis?

The full report lives at /stocks/ACIU/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ACIU?

The latest report frames ACIU around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ACIU page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.